Alaunos Therapeutics (TCRT) Other Gross PP&E Adjustments (2016 - 2024)
Alaunos Therapeutics (TCRT) has disclosed Other Gross PP&E Adjustments for 14 consecutive years, with -$64000.0 as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Other Gross PP&E Adjustments rose 90.88% year-over-year to -$64000.0, compared with a TTM value of -$64000.0 through Dec 2024, up 90.88%, and an annual FY2024 reading of -$64000.0, up 90.88% over the prior year.
- Other Gross PP&E Adjustments was -$64000.0 for Q4 2024 at Alaunos Therapeutics, up from -$702000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $15.6 million in Q4 2022 and bottomed at -$5.4 million in Q2 2021.
- Average Other Gross PP&E Adjustments over 5 years is -$5235.3, with a median of -$2.0 million recorded in 2023.
- Peak annual rise in Other Gross PP&E Adjustments hit 100.14% in 2021, while the deepest fall reached 185.24% in 2021.
- Year by year, Other Gross PP&E Adjustments stood at $6.6 million in 2020, then soared by 100.14% to $13.1 million in 2021, then increased by 18.98% to $15.6 million in 2022, then plummeted by 104.5% to -$702000.0 in 2023, then soared by 90.88% to -$64000.0 in 2024.
- Business Quant data shows Other Gross PP&E Adjustments for TCRT at -$64000.0 in Q4 2024, -$702000.0 in Q4 2023, and -$1.0 million in Q3 2023.